Allogene Therapeutics Inc (ALLO) Insider Trading
- $21,747,917.40
- $117,099,790.39
- Dec. 18, 2023
- Veer Bhavnagri
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 14, 2019 | Major Shareholder | 1,918,755 | $29.38 | Sell | $56,373,021.90 | |
| Oct. 15, 2018 | Major Shareholder | 675,000 | $18.00 | Buy | $12,150,000.00 | |
| Oct. 15, 2018 | Director | 35,000 | $18.00 | Buy | $630,000.00 | |
| Oct. 15, 2018 | Insider | 40,000 | $18.00 | Buy | $720,000.00 |
Insiders are both buying and selling Allogene Therapeutics Inc stock.
The insider traders at Allogene Therapeutics Inc are: Veer Bhavnagri, Group Holdings (Sbs) Advis Tpg, Alison Moore, Rafael Amado, Eric Thomas Schmidt, Owen N Witte, Arie Belldegrun, David D Chang, Deborah M Messemer, Stephen Mayo, and Owen N. Witte
The most active insider trader at Allogene Therapeutics Inc is Veer Bhavnagri with 11 trades.
Group Holdings (Sbs) Advis Tpg has sold the most Allogene Therapeutics Inc stock with a total value of $100,842,593.44.
Group Holdings (Sbs) Advis Tpg has bought the most Allogene Therapeutics Inc stock with a total value of $24,300,000.00.
The most recent insider trade for Allogene Therapeutics Inc was on Dec. 18, 2023.
The single biggest insider buy for Allogene Therapeutics Inc was from Group Holdings (Sbs) Advis Tpg with a total value of $12,150,000.00 on Oct. 15, 2018.
The single biggest insider sell for Allogene Therapeutics Inc was from Group Holdings (Sbs) Advis Tpg with a total value of $56,373,021.90 on May 14, 2019.